200 related articles for article (PubMed ID: 14749843)
1. The treatment of atopic dermatitis and other dermatoses with leukotriene antagonists.
Rackal JM; Vender RB
Skin Therapy Lett; 2004 Feb; 9(2):1-5. PubMed ID: 14749843
[TBL] [Abstract][Full Text] [Related]
2. [Leukotriene receptor antagonists--possible therapeutic option in the treatment of atopic dermatitis ].
Czarnecka-Operacz M; Jenerowicz D
Pol Merkur Lekarski; 2003 Jan; 14(79):86-8. PubMed ID: 12712839
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Hotline: Cysteinyl leukotriene receptor antagonist montelukast in the treatment of atopic dermatitis.
Broshtilova V; Gantcheva M
Dermatol Ther; 2010; 23(1):90-3. PubMed ID: 20136913
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast.
Angelova-Fischer I; Tsankov N
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):115-9. PubMed ID: 16200338
[TBL] [Abstract][Full Text] [Related]
5. Cytokine production, activation marker, and skin homing receptor in children with atopic dermatitis and bronchial asthma.
Antúnez C; Torres MJ; Mayorga C; Corzo JL; Jurado A; Santamaría-Babi LF; Vera A; Blanca M
Pediatr Allergy Immunol; 2006 May; 17(3):166-74. PubMed ID: 16672002
[TBL] [Abstract][Full Text] [Related]
6. Brief case series: montelukast, at doses recommended for asthma treatment, reduces disease severity and increases soluble CD14 in children with atopic dermatitis.
Hon KL; Leung TF; Ma KC; Wong Y; Fok TF
J Dermatolog Treat; 2005 Feb; 16(1):15-8. PubMed ID: 15897161
[TBL] [Abstract][Full Text] [Related]
7. A role for leukotriene antagonists in atopic dermatitis?
Chari S; Clark-Loeser L; Shupack J; Washenik K
Am J Clin Dermatol; 2001; 2(1):1-6. PubMed ID: 11702615
[TBL] [Abstract][Full Text] [Related]
8. Atopic dermatitis: immunobiology and treatment with immune modulators.
Leung DY
Clin Exp Immunol; 1997 Jan; 107 Suppl 1():25-30. PubMed ID: 9020932
[TBL] [Abstract][Full Text] [Related]
9. Montelukast in general pediatric practices.
Ngamphaiboon J
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S348-51. PubMed ID: 16623053
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene receptor antagonists: clinical potential in allergic rhinitis.
Diamant Z; Fokkens WJ
Rhinology; 2001 Dec; 39(4):187-90. PubMed ID: 11826686
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-3, interleukin-8, FMLP and C5a enhance the release of leukotrienes from neutrophils of patients with atopic dermatitis.
Neuber K; Hilger RA; König W
Immunology; 1991 May; 73(1):83-7. PubMed ID: 2045129
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids.
Rubin P; Mollison KW
Prostaglandins Other Lipid Mediat; 2007 May; 83(3):188-97. PubMed ID: 17481554
[TBL] [Abstract][Full Text] [Related]
13. Impaired responses of peripheral blood mononuclear cells to nickel in patients with nickel-allergic contact dermatitis and concomitant atopic dermatitis.
Buchvald D; Lundeberg L
Br J Dermatol; 2004 Mar; 150(3):484-92. PubMed ID: 15030331
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
Friedmann PS; Palmer R; Tan E; Ogboli M; Barclay G; Hotchkiss K; Berth-Jones J
Clin Exp Allergy; 2007 Oct; 37(10):1536-40. PubMed ID: 17850382
[TBL] [Abstract][Full Text] [Related]
15. [Role of leukotriene antagonists in non-asthmatic disorders].
Pescollderungg L
Minerva Pediatr; 2004 Apr; 56(2):151-5. PubMed ID: 15249898
[TBL] [Abstract][Full Text] [Related]
16. Advances in therapy with antileukotriene drugs.
Riccioni G; Di Ilio C; Conti P; Theoharides TC; D'Orazio N
Ann Clin Lab Sci; 2004; 34(4):379-87. PubMed ID: 15648777
[TBL] [Abstract][Full Text] [Related]
17. 927T>C polymorphism of the cysteinyl-leukotriene type-1 receptor (CYSLTR1) gene in children with asthma and atopic dermatitis.
Arriba-Mendez S; Sanz C; Isidoro-Garcia M; Davild I; Laffond E; Horeno E; Avila C; Lorente F
Pediatr Allergy Immunol; 2006 Aug; 17(5):323-8. PubMed ID: 16846449
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene receptor antagonists--a novel therapeutic approach in atopic dermatitis?
Kägi MK
Dermatology; 2001; 203(4):280-3. PubMed ID: 11752812
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological modulation of the leukotriene pathway in allergic airway disease.
Montuschi P; Sala A; Dahlén SE; Folco G
Drug Discov Today; 2007 May; 12(9-10):404-12. PubMed ID: 17467577
[TBL] [Abstract][Full Text] [Related]
20. A systematic review on the off-label use of montelukast in atopic dermatitis treatment.
Chin WK; Lee SWH
Int J Clin Pharm; 2018 Oct; 40(5):963-976. PubMed ID: 29777328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
